Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Mar;11(3):155-9.
doi: 10.1038/nrn2786. Epub 2009 Dec 23.

Prion-like mechanisms in neurodegenerative diseases

Bess Frost  1 , Marc I Diamond
Affiliations
Review

Prion-like mechanisms in neurodegenerative diseases

Bess Frost et al. Nat Rev Neurosci. 2010 Mar.

Abstract

Many non-infectious neurodegenerative diseases are associated with the accumulation of fibrillar proteins. These diseases all exhibit features that are reminiscent of those of prionopathies, including phenotypic diversity and the propagation of pathology. Furthermore, emerging studies of amyloid-beta, alpha-synuclein and tau--proteins implicated in common neurodegenerative diseases--suggest that they share key biophysical and biochemical characteristics with prions. Propagation of protein misfolding in these diseases may therefore occur through mechanisms similar to those that underlie prion pathogenesis. If this hypothesis is verified in vivo, it will suggest new therapeutic strategies to block propagation of protein misfolding throughout the brain.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1. Potential mechanisms for trans-cellular propagation of protein misfolding
(A) Intracellular protein aggregation leads to cell death. This results in release of protein aggregates into the extracellular space, which are subsequently taken up and corrupt protein folding in vulnerable cells. (B) As part of the physiology of a living cell, protein aggregates may be released, potentially via exosomes or exocytosis. This results in protein aggregates in the extracellular space that may be taken up by adjacent cells. This mechanism can account for local propagation of misfolding, along with (A). (C) Aggregates might cross synapses. Release could be due to local degeneration of a synapse, normal synaptic physiology, or as part of an exocytic process as in (B). This mechanism can explain network degeneration in neurodegenerative diseases.
Figure 2
Figure 2. New therapeutic approaches
If trans-cellular propagation of protein misfolding occurs, then new strategies could supplement existing approaches to promote cell survival and block intracellular accumulation of misfolded species. As the cellular mechanisms of aggregate release and uptake are delineated, it may be possible to inhibit these events pharmacologically or genetically. Antibody-based therapies might also be expanded to target protein aggregates that are generated inside a cell and released into the extracellular space.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science. 1982;216:136–44. - PubMed
    1. Caughey B, Race RE, Chesebro B. Detection of prion protein mRNA in normal and scrapie-infected tissues and cell lines. J Gen Virol. 1988;69 ( Pt 3):711–6. - PubMed
    1. Pan KM, et al. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci U S A. 1993;90:10962–6. - PMC - PubMed
    1. Prusiner SB. Prions. Proc Natl Acad Sci U S A. 1998;95:13363–83. - PMC - PubMed
    1. Williamson J, Goldman J, Marder KS. Genetic aspects of Alzheimer disease. Neurologist. 2009;15:80–6. - PMC - PubMed

Publication types